Gene · 5140
Papers1,572
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,572
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering hierarchical regulatory network of cell fate via an epigenetics-informed heterogeneous graph transformer on single-cell multi-omics data. | Brief Bioinform | 2025 | 41643202 | PubTator, text mining | PubMed |
| Covalent Binding of the Boronic Acid-Based Inhibitor GSK4394835A to Phosphodiesterase 3B, a Drug Target for Cardiovascular Disease. | J Med Chem | 2025 | 41331906 | PubTator, text mining | PubMed |
| Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors? | Cells | 2025 | 41227315 | PubTator, text mining | PubMed |
| PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3-L1 adipocytes. | Br J Pharmacol | 2025 | 41082906 | PubTator, text mining | PubMed |
| An attention-based mRNA transformer network for accurate prediction of melanoma response to immune checkpoint inhibitors. | Sci Rep | 2025 | 40883359 | PubTator, text mining | PubMed |
| Mitochondrial Damage-induced Ferroptosis: The Molecular Mechanism by Which Psoralen Inhibits the Proliferation and Invasion of Non-small-cell Lung Cancer Cells. | In Vivo | 2025 | 40877163 | PubTator, text mining | PubMed |
| Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation. | Med Sci (Basel) | 2025 | 40843747 | PubTator, text mining | PubMed |
| Clinacanthus nutans (Burm.f.) Lindau facilitates cuproptosis and ameliorates colon cancer progression by inhibiting PDE3B-mediated Apelin pathway. | Discov Oncol | 2025 | 40788438 | PubTator, text mining | PubMed |
| Enhanced genetic fine mapping accuracy with Bayesian Linear Regression models in diverse genetic architectures. | PLoS Genet | 2025 | 40737338 | PubTator, text mining | PubMed |
| Heterogeneous expression of long noncoding RNA RP11-109D20.2: Insights into regulatory gene expression roles in colon cancer. | Iran J Basic Med Sci | 2025 | 40666182 | PubTator, text mining | PubMed |
| PDE3B and HBB are key prognostic biomarkers driving cell proliferation and regulating immune microenvironment in breast cancer. | Hereditas | 2025 | 40462176 | PubTator, text mining | PubMed |
| Radiation dosimetry of [11C]TZ1964B as determined by whole-body PET imaging of nonhuman primates. | EJNMMI Res | 2025 | 40369374 | PubTator, text mining | PubMed |
| Identification of prognostic and therapeutic biomarkers associated with macrophage and lipid metabolism in pancreatic cancer. | Sci Rep | 2025 | 40281115 | PubTator, text mining | PubMed |
| miR-135b-5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial-Mesenchymal Transition. | Mol Carcinog | 2025 | 40170518 | PubTator, text mining | PubMed |
| Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma. | World J Clin Oncol | 2025 | 40130053 | PubTator, text mining | PubMed |
| Cyclic nucleotide phosphodiesterases as drug targets. | Pharmacol Rev | 2025 | 40081105 | PubTator, text mining | PubMed |
| Integrated Metabolomic and Transcriptomic Analysis Revealed the Mechanism of BHPF Exposure in Endometrium. | Toxics | 2025 | 39997915 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Hypometric genetics: Improved power in genetic discovery by incorporating quality control flags. | Am J Hum Genet | 2024 | 39442521 | PubTator, text mining | PubMed |
| Secondary Transcriptomic Analysis of Triple-Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific Mechanistic Markers. | Cancers (Basel) | 2024 | 39409999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5140/papers?page=2